Kymera drug positioned to rival Sanofi and Regeneron’s Dupixent succeeds in early-stage eczema trial There were early hints the drug’s benefits might extend to diseases like asthma

https://www.statnews.com/2025/12/08/kymera-kt-621-clinical-trial-results-atopic-dermatitis-challenge-dupixent/ By Jonathan WosenDec. 8, 2025 West Coast Biotech & Life Sciences Reporter Working with monkeys was this lab tech’s dream job. Now she’s staffing an IT help desk Experts worry that funding uncertainty under Trump will drive others from science, too By Jonathan Wosen https://www.statnews.com/2025/12/04/research-cut-impacts-early-career-scientists-american-science-shattered-series/